VEGF121, His & Avi, Human
VEGF121, His & Avi, Human

Immobilized VEGF121, His & Avi, Human, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Human VEGF R1, His Tag with the EC50 of 0.12 μg/ml determined by ELISA.

VEGF121, His & Avi, Human

VEGF121, His & Avi, Human on Bis-Tris PAGE under reduced (R) condition and Non reducing (N) condition. The purity is greater than 95%.

VEGF121, His & Avi, Human

Vascular endothelial growth factor (VEGF or VEGF-A), also known as vascular permeability factor (VPF), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189.
Z05952
¥80,213.00

Ask us a question
Product Introduction
Species Human
Protein Construction
VEGF121 (Ala27-Arg147)
Accession # P15692-9		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 17 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS,250mM Arginine (pH 7.4)
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • VEGF121, His & Avi, Human
    • VEGF121, His & Avi, Human

    Immobilized VEGF121, His & Avi, Human, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Biotinylated Human VEGF R1, His Tag with the EC50 of 0.12 μg/ml determined by ELISA.

  • VEGF121, His & Avi, Human
    • VEGF121, His & Avi, Human

    VEGF121, His & Avi, Human on Bis-Tris PAGE under reduced (R) condition and Non reducing (N) condition. The purity is greater than 95%.


Background
Target Background Vascular endothelial growth factor (VEGF or VEGF-A), also known as vascular permeability factor (VPF), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. VEGF165 appears to be the most abundant and potent isoform, followed by VEGF121 and VEGF189.
Synonyms VEGF; VEGFA; MVCD1; VAS; VEGFMGC70609; VPF; RP1-261G23.1; MGC70609

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.